3 results match your criteria: "and Center for Beta Cell Therapy[Affiliation]"
Am J Physiol Endocrinol Metab
October 2016
Diabetes Research Center, Brussels Free University-VUB, University Hospital Brussels, and Center for Beta Cell Therapy, Brussels, Belgium
Compounds that increase β-cell number can serve as β-cell replacement therapies in diabetes. In vitro studies have identified several agents that can activate DNA synthesis in primary β-cells but only in small percentages of cells and without demonstration of increases in cell number. We used whole well multiparameter imaging to first screen a library of 1,280 compounds for their ability to recruit adult rat β-cells into DNA synthesis and then assessed influences of stimulatory agents on the number of living cells.
View Article and Find Full Text PDFPLoS One
September 2014
Diabetes Pathology and Therapy Unit, Diabetes Research Center and Center for Beta Cell Therapy, Brussels Free University-VUB, Brussels, Belgium.
Background: Glucose effects on beta cell survival and DNA-synthesis suggest a role as regulator of beta cell mass but data on beta cell numbers are lacking. We examined outcome of these influences on the number of beta cells isolated at different growth stages in their population.
Methods: Beta cells from neonatal, young-adult and old rats were cultured serum-free for 15 days.
PLoS One
February 2013
Diabetes Research Center, Brussels Free University-VUB, and Center for Beta Cell Therapy in Diabetes, Brussels, Belgium.
Background: Pancreatic-tail duct ligation (PDL) in adult rodents has been reported to induce beta cell generation and increase beta cell mass but increases in beta cell number have not been demonstrated. This study examines whether PDL increases beta cell number and whether this is caused by neogenesis of small clusters and/or their growth to larger aggregates.
Methodology: Total beta cell number and its distribution over small (<50 µm), medium, large (>100 µm) clusters was determined in pancreatic tails of 10-week-old mice, 2 weeks after PDL or sham.